Ivermectin

Ivermectin Reactions 1680, p196 - 2 Dec 2017 Variou toxicities: 4 case reports In a retrospective study, an 18-year-old boy developed body pain and general fatigue, a 33-year-old man developed headache, a 25-year-old man developed aching eyes, headache and dizziness and a 28-year-old man developed increased itching and dizziness following treatment with ivermectin [dosage and outcomes not stated]. An 18-year-old boy developed body pain and general fatigue following treatment with ivermectin. The boy, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with body pain and general fatigue. The events were treated symptomatically and no new medical visits were required. A 33-year-old man developed headache following treatment with ivermectin. The man, who was a Syrian refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with headache. The events were treated symptomatically and no new medical visits were required. A 25-year-old man developed aching eyes, headache and dizziness following treatment with ivermectin. The man, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with aching eyes, headache and dizziness. The events were treated symptomatically and no new medical visits were required. A 28-year-old man developed increased itching and dizziness following treatment with ivermectin. The man, who was an Afghan refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. He had pre-existing itching for 3.5 weeks. The day after ivermectin was started, he presented with increased itching and dizziness. The events were treated symptomatically and no new medical visits were required. Author comment: Headache, dizziness, increased itching and abnormal sensations in the eye are described in the summary of product characteristics as a side effect of ivermectin. Typical [ivermectin] side effects: Itching, gastrointestinal symptoms, dizziness, headaches, allergies, swollen lymph nodes, fever, headache and muscle pain, low blood pressure. Solbach P, et al. Mass therapy with ivermectin for scabies outbreak during the refugee crisis in Germany in 2015. [German]. Anasthesiologie and Intensivmedizin 58: 534-541, No. 10, Oct 2017. Available from: URL: http://doi.org/10.19224/ ai2017.534 [German; summarised from a translation] - Germany 803284281 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Ivermectin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/ivermectin-UKrFgv2H9p
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39127-7
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p196 - 2 Dec 2017 Variou toxicities: 4 case reports In a retrospective study, an 18-year-old boy developed body pain and general fatigue, a 33-year-old man developed headache, a 25-year-old man developed aching eyes, headache and dizziness and a 28-year-old man developed increased itching and dizziness following treatment with ivermectin [dosage and outcomes not stated]. An 18-year-old boy developed body pain and general fatigue following treatment with ivermectin. The boy, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with body pain and general fatigue. The events were treated symptomatically and no new medical visits were required. A 33-year-old man developed headache following treatment with ivermectin. The man, who was a Syrian refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with headache. The events were treated symptomatically and no new medical visits were required. A 25-year-old man developed aching eyes, headache and dizziness following treatment with ivermectin. The man, who was an Iraqi refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. The day after ivermectin was started, he presented with aching eyes, headache and dizziness. The events were treated symptomatically and no new medical visits were required. A 28-year-old man developed increased itching and dizziness following treatment with ivermectin. The man, who was an Afghan refugee had scabies and he was treated with oral ivermectin in a first reception centre for mass treatment of scabies infestations. He had pre-existing itching for 3.5 weeks. The day after ivermectin was started, he presented with increased itching and dizziness. The events were treated symptomatically and no new medical visits were required. Author comment: Headache, dizziness, increased itching and abnormal sensations in the eye are described in the summary of product characteristics as a side effect of ivermectin. Typical [ivermectin] side effects: Itching, gastrointestinal symptoms, dizziness, headaches, allergies, swollen lymph nodes, fever, headache and muscle pain, low blood pressure. Solbach P, et al. Mass therapy with ivermectin for scabies outbreak during the refugee crisis in Germany in 2015. [German]. Anasthesiologie and Intensivmedizin 58: 534-541, No. 10, Oct 2017. Available from: URL: http://doi.org/10.19224/ ai2017.534 [German; summarised from a translation] - Germany 803284281 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off